Cost-effectiveness analysis 2.0

New England Journal of Medicine

Volumn 376, Issue 3, 2017, Pages 203-205

  Neumann, Peter J ^a   Sanders, Gillian D ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MEDICARE; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; REVIEW; COST BENEFIT ANALYSIS; ECONOMICS; ETHICS; HEALTH CARE COST; PROCEDURES; STANDARDS; UNITED STATES;

COST-BENEFIT ANALYSIS; GUIDELINES AS TOPIC; HEALTH CARE COSTS; HEALTH CARE RATIONING; HUMANS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 85010936350     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1612619     Document Type: Review

References (5)

1. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
2. Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost Effectiveness in Health and Medicine. JAMA 2016; 316: 1093-103.
3. Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, eds. Cost-effectiveness in health and medicine. 2nd ed. New York: Oxford University Press, 2016.
4. Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2304-22.
5. Institute for Clinical and Economic Review. ICER value assessment framework: 1.0 to 2.0. 2016 (http://icer-review.org/wp-content/uploads/2016/02/Value-Assessment-Framework-slides-for-July-29-webinar-FINAL.pdf).